News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Crucell N.V. (CRXL) To Offer $449 Million For Berna Biotech AG



12/1/2005 11:18:07 AM

AMSTERDAM/ZURICH, Dec 1 (Reuters) - Dutch biotech firm Crucell (CRCL.AS: Quote, Profile, Research) announced a 591 million Swiss franc ($449.4 million) bid for Berna Biotech (BBIN.S: Quote, Profile, Research) on Thursday, offering a premium based on its hopes for Berna's vaccines business.

Read at Reuters

Related News

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES